Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
13.09
+0.49 (3.89%)
At close: Jul 2, 2026, 4:00 PM EDT
12.83
-0.26 (-1.99%)
After-hours: Jul 2, 2026, 7:52 PM EDT
Q32 Bio Revenue
In the year 2025, Q32 Bio had annual revenue of $53.74M.
Revenue (ttm)
$53.74M
Revenue Growth
n/a
P/S Ratio
4.13
Revenue / Employee
$2,442,591
Employees
22
Market Cap
221.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 53.74M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | -6.65M | -9.86M | - |
| Dec 31, 2022 | 3.21M | -30.76M | -90.56% |
| Dec 31, 2021 | 33.97M | 31.27M | 1,157.25% |
| Dec 31, 2020 | 2.70M | 1.04M | 62.18% |
| Dec 31, 2019 | 1.67M | -3.66M | -68.70% |
| Dec 31, 2018 | 5.32M | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Karyopharm Therapeutics | 151.12M |
| Codexis | 78.09M |
| Compugen | 72.66M |
| Coherus Oncology | 46.88M |
| Voyager Therapeutics | 36.49M |
| Keros Therapeutics | 33.18M |
| Whitehawk Therapeutics | 7.15M |
| Armata Pharmaceuticals | 5.20M |
QTTB News
- 10 days ago - Q32 Bio files $300M mixed securities shelf - TheFly
- 10 days ago - Q32 Bio Registration statement: Registration filing - Filings
- 23 days ago - Q32 Bio Transcript: AGM 2026 - Transcripts
- 5 weeks ago - 3 Penny Stocks to Watch Now, 5/28/26 - TipRanks
- 5 weeks ago - Q32 Bio Inc trading halted, volatility trading pause - TheFly
- 5 weeks ago - Q32 Bio Inc trading resumes - TheFly
- 5 weeks ago - Q32 Bio announces $55M private placement - TheFly
- 5 weeks ago - Q32 Bio Announces $55 Million Private Placement Financing - PRNewsWire